Overview

An Open-label Trial to Determine Increased Red Blood Cell Production in Subjects With Anemia of Chronic Disease

Status:
Unknown status
Trial end date:
2013-09-01
Target enrollment:
Participant gender:
Summary
The objective of this study is to measure the change in blood values after the administration of an amino acid based erythropoietin stimulating system.
Phase:
Phase 3
Details
Lead Sponsor:
Targeted Medical Pharma
Treatments:
Epoetin Alfa